Shasun Pharmaceuticals fell 3.61% to Rs 61.50 at 14:08 IST on BSE on profit booking after the stock rose 9.53% in the preceding three trading sessions to Rs 63.80 on 2 September 2013 from a recent low of Rs 58.25 on 28 August 2013.
Meanwhile, the BSE Sensex was down 420.92 points, or 2.23%, to 18,465.21.
On BSE, 27,000 shares were traded in the counter compared with average volume of 1.25 lakh shares in the past one quarter.
The stock hit a high of Rs 64.45 and a low of Rs 61.20 so far during the day. The stock hit a record high of Rs 185.90 on 10 September 2012. The stock hit a 52-week low of Rs 45.60 on 26 June 2013.
The stock had outperformed the market over the past one month till 2 September 2013, rising 22.22% compared with the Sensex's 1.45% decline. The scrip had, however, underperformed the market in past one quarter, falling 8.53% as against Sensex's 4.42% fall.
The small-cap company has an equity capital of Rs 11.32 crore. Face value per share is Rs 2.
Also Read
Recent rise in Shasun Pharmaceuticals shares was triggered by the company successfully completing MHRA inspection during the third week of August 2013.
The company during trading hours on Friday, 30 August 2013, said it successfully completed MHRA inspection during the third week of August 2013. Shasun Pharmaceuticals said that the main focus of MHRA inspection was to conduct cGMP audit for the company's formulation facility. The stock jumped 5.54% to Rs 61.95 on Friday, 30 August 2013.
Shasun Pharmaceuticals reported a consolidated net loss of Rs 6.57 crore in Q1 June 2013, as against net profit of Rs 13.82 crore in Q1 June 2012. Net sales declined 13.5% to Rs 216.70 crore in Q1 June 2013 over Q1 June 2012.
Shasun is an integrated, leading global supplier of development and manufacturing services for intermediates, API and formulations to the pharmaceutical industry.
Powered by Capital Market - Live News